Meta-Analysishigh evidence

Duchenne Muscular Dystrophy and Delandistrogene Moxeparvovec Gene Therapy in Children: A Systematic Review and Meta-Analysis.

Neurology. Genetics·August 1, 2026·PMID 42396397

Why it matters

This analysis provides pooled evidence that gene therapy can improve functional outcomes and restore dystrophin in young ambulatory DMD patients, addressing a critical unmet need beyond corticosteroids and supportive care.

Infographic summary of Duchenne Muscular Dystrophy and Delandistrogene Moxeparvovec Gene Therapy in Children: A Systematic Review and Meta-Analysis.
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled